- Home
- COCH vs DXR Comparison
COCH vs DXR Comparison
Compare COCH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COCH | DXR |
|---|---|---|
| Founded | 1995 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 59.0M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | COCH | DXR |
|---|---|---|
| Price | $0.71 | $10.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 82.9K | 6.0K |
| Earning Date | 05-08-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $241,000.00 | ★ $1,446,345.00 |
| Revenue This Year | $1.58 | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ 7.11 | N/A |
| 52 Week Low | $0.36 | $8.56 |
| 52 Week High | $1.89 | $14.76 |
Technical Indicators
Market Signals| Indicator | COCH | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 52.97 |
| Support Level | $0.63 | $9.38 |
| Resistance Level | $0.76 | $10.99 |
| Average True Range (ATR) | 0.03 | 0.48 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 58.39 | 67.93 |
Price Performance
Historical ComparisonAbout COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.